Page 12 - Company Results

Bajaj Auto Q4 profit more than doubles to ₹3,662 crore on record volumes

Bajaj Auto reported strong Q4 FY26 earnings, driven by record volumes, export growth, improved product mix and rising contribution from electric vehicles

Meesho narrows Q4 net loss 88% to Rs 166 crore, revenue rises 47%

E-commerce firm reports higher orders and improving margins in the March quarter as operating leverage and lower logistics costs support profitability

Paytm posts net profit of Rs 184 crore in Q4, revenue rises 18.4%

One97 Communications reported a consolidated net profit of Rs 184 crore in Q4 FY26, supported by higher revenue and controlled indirect expenses

Bajaj Auto quarterly profit beats view on strong domestic, overseas demand

Securities and Exchange Board of India clears key leadership appointments at National Stock Exchange to strengthen governance and oversight at market infrastructure institutions

GCPL Q4 results: Profit rises 9.6% to ₹451 cr, FY26 revenue up 7.9%

GCPL posts steady Q4 growth driven by domestic volumes and cost control, with management confident of sustained momentum in FY27

South Indian Bank Q4 results: Net profit rises 19.3% to ₹408 crore

South Indian Bank reported a 19.3 per cent rise in fourth-quarter net profit, helped by a sharp fall in provisions and steady growth in loans and deposits

ABREL posts Q4 profit of Rs 11 crore despite decline in bookings

Aditya Birla Real Estate posted a profit in Q4 FY26 against a year-ago loss, though quarterly residential bookings and collections declined year-on-year

KPI Green Energy Q4 results: Net profit surges 49% to ₹155 crore

During the fourth quarter, the company's total revenue rose to ₹810.20 crore from ₹577.80 crore in the January-March period of the 2024-25 financial year

Q4 results: Bajaj Auto, Paytm, Meesho, Polycab India, 58 more on May 6

Q4FY26 company results: Firms including Shree Cements, Godrej Consumer Products, PB Fintech, Blue Star, and Raymond Lifestyle are also to release their January-March earnings today

L&T Q4FY26 results: Net profit declines 3% to ₹5,325.60 cr; revenue up 11%

L&T posts marginal decline in Q4 profit due to base effect, while revenue grows 11% on strong order inflow; board recommends Rs 38 per share dividend

M&M Q4FY26 results: PAT up 42% on strong momentum across businesses

Mahindra & Mahindra reports a 42% rise in Q4 PAT to Rs 4,668 crore, driven by strong performance in auto, farm and services businesses, alongside steady growth in EVs

PNB Q4 result: Profit rises 14.4% to ₹5,225 crore; asset quality improves

On the asset quality front, the bank's gross Non-Performing Assets (NPAs) improved to 2.95 per cent of gross advances as compared to 3.95 per cent by the end of March 2025

Hero MotoCorp net up 26.1% on GST cuts, broad-based growth in ICE

Hero MotoCorp reports 26.1% rise in Q4FY26 net profit, driven by strong demand, GST rate rationalisation, and growth across domestic and global markets

Kumar Mangalam Birla appointed as Non-Executive Chairman of Vodafone Idea

Board appoints KM Birla as Non-Executive Chairman as Vodafone Idea benefits from AGR relief and prepares for fundraising and network expansion

Ajanta Pharma Q4 FY26 results: Net profit rises 18.4% to ₹266.7 crore

The company had posted a consolidated net profit of ₹225.26 crore in the corresponding period previous fiscal, Ajanta Pharma Ltd said in a regulatory filing

Emcure Pharmaceuticals Q4 results: Profit jumps 28%, revenue up by 16%

The rise in profits was attributed to the robust performance in international markets and growth in new launches from Emcure's in-house portfolio

L&T Q4 FY26 results: Net profit dips 3.1% to ₹5,326 crore, new CFO named

The company also named P Ramakrishnan ‌as it next chief financial officer

Marico Q4FY26 result: Net profit rises 18% to ₹408 crore on strong growth

Its consolidated revenue from operations in the fourth quarter stood at ₹3,333 crore compared to ₹2,730 crore in the year-ago period

Emcure Pharmaceuticals Q4 results: Net profit rises 24% to ₹243.74 crore

The company had posted a consolidated net profit of ₹197.24 crore in the corresponding quarter last fiscal, Emcure Pharmaceuticals Ltd said in a regulatory filing

Raymond Q4FY26 result: Net profit falls 53% to ₹11.93 crore; revenue rises

Total expenses in the quarter under review were higher at ₹587.14 crore as compared to ₹556.85 crore in the year-ago period